Pharmacy benefit managers are changing the way that prescriptions are filled, reducing the costs for patients and increasing the value for all involved. Read More »

Aytu BioScience Inc. has two new posters that exhibit the use of the MiOXSYS System, a tool developed by the company for determining oxidative stress in human semen. Read More »

Biologics Inc., a McKesson Specialty Health company, has been selected by Takeda Pharmaceutical Co. to be a “specialty pharmacy provider” for ALUNBRIG, a Takeda-manufactured drug for anaplastic lymphoma kinase positive metastatic non-small cell lung cancer. Read More »

The drug Kalydeco was recently approved to treat additional case of gene mutations in cystic fibrosis patients, the U.S. Food and Drug Administration reported on May 17 in a press release. Read More »

The FDA recently approved Abon Pharmaceuticals' Abbreviated New Drug Application for its Clofarabine Injection as a treatment for pediatric patients who suffer from relapsed or refractory acute lymphoblastic leukemia, a deadly cancer disease. Read More »

fred’s Pharmacy was pleased to report they screened over 98,000 people for heart disease and detection during their Heart Disease Awareness and Colorectal Cancer Campaigns, and made a huge donation of $38,244 to the American Heart Association this month. Read More »

60 Degrees Pharmaceuticals' study findings on tafenoquine have been published in Travel Medicine and Infectious Disease. Read More »

Express Scripts has acquired myMatrixx to combine its integrated pharmacy benefit management services with myMatrixx's workers' compensation pharmacy benefits experience. Read More »

GE Healthcare is working alongside of Check-Cap on the development and validation of a cancer-screening process. Read More »

Portola Pharmaceuticals Inc.'s clinical results from a study will be presented during the International Conference on Malignant Lymphoma. Read More »

The American Society of Hospital Pharmacists (ASHP) recently announced that a new AHFS Drug Information (AHFS DI) has been released. Read More »

Envisia Therapeutics has released an interim analysis on the second cohort of its ENV515 (travoprost XR) Phase 2 trial, which involves patients with glaucoma. Read More »

Fred’s Inc.'s plans to buy 865 Rite Aid stores for $950 million is still active. Read More »

Zimmer Biomet Holdings' Gel-One Cross-linked Hyaluronate has been approved by the U.S. Food and Drug Administration. Read More »

CVS Health will nationally sponsor the American Heart Association’s Go Red For Women and pledge to raise $10 million over the next three years in support of life-saving cardiovascular research and education. Read More »

The U.S. Food and Drug Administration has approved Siliq (brodalumab) as a treatment for adults with moderate-to-severe plaque psoriasis. Read More »

Advanced Pharma Inc., which does business as Avella of Houston, is voluntarily recalling unexpired sterile injectable products labeled "latex free" that were produced at the company’s Houston location between Sep. 1, 2016 and Feb. 16, 2017. Read More »

The Academy of Managed Care Pharmacy's members are urging Congress and President Donald Trump's administration to include comprehensive pharmacy benefits in any health care reform bill they attempt to pass. Read More »

Valeant Pharmaceuticals Inc. and EyeGate Pharmaceuticals have entered an exclusive, global licensing agreement. Read More »

A patent application has been filed for a new cannabinoid-based topical therapy that will treat glaucoma, the second-leading cause of blindness. Read More »